PEPITEM

PEPITEM
Identifiers
  • L-seryl-L-valyl-L-threonyl-L-α-glutamyl-L-glutaminylglycyl-L-alanyl-L-α-glutamyl-L-leucyl-L-seryl-L-asparaginyl-L-α-glutamyl-L-α-glutamyl-L-Arginine
CAS Number
PubChem CID
Chemical and physical data
FormulaC61H101N19O28
Molar mass1548.584 g·mol−1
3D model (JSmol)
  • O=C(N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@H](O)C)CCC(=O)O
  • InChI=1S/C61H101N19O28/c1-25(2)20-36(55(102)78-38(24-82)57(104)77-37(21-40(64)85)56(103)73-32(11-16-43(89)90)51(98)72-33(12-17-44(91)92)53(100)75-35(60(107)108)8-7-19-67-61(65)66)76-54(101)31(10-15-42(87)88)70-48(95)27(5)69-41(86)22-68-50(97)30(9-14-39(63)84)71-52(99)34(13-18-45(93)94)74-59(106)47(28(6)83)80-58(105)46(26(3)4)79-49(96)29(62)23-81/h25-38,46-47,81-83H,7-24,62H2,1-6H3,(H2,63,84)(H2,64,85)(H,68,97)(H,69,86)(H,70,95)(H,71,99)(H,72,98)(H,73,103)(H,74,106)(H,75,100)(H,76,101)(H,77,104)(H,78,102)(H,79,96)(H,80,105)(H,87,88)(H,89,90)(H,91,92)(H,93,94)(H,107,108)(H4,65,66,67)/t27-,28+,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,46-,47-/m0/s1
  • Key:FNMDPJXMBAIAGR-WSBPUMMXSA-N

PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration) is an endogenous polypeptide composed of the 14 amino acids 28–41 of the 14.3.3.ζδ protein, which in turn is a 245 amino-acid product of the YWHAZ gene. It has the sequence SVTEQGAELSNEER. PEPITEM has antiinflammatory effects by inhibiting trafficking of T cells into inflamed tissues. Levels of PEPITEM in the body decline with age, diabetes or rheumatoid arthritis, and decreased PEPITEM levels correlates with increases in chronic inflammation and numerous resulting health issues. Administration of synthetic PEPITEM has been suggested as a treatment for various conditions where inflammation plays a role.[1][2][3][4][5][6][7] Some smaller fragments derived from the sequence of PEPITEM such as SVT-NH-ethyl may also produce similar activity to the full length peptide, but more research and clinical trials are required.[8][9]

See also

References

  1. ^ Chimen M, McGettrick HM, Apta B, Kuravi SJ, Yates CM, Kennedy A, et al. (May 2015). "Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease". Nature Medicine. 21 (5): 467–475. doi:10.1038/nm.3842. PMC 4425550. PMID 25894827.
  2. ^ Matsubara H, Shimizu Y, Arai M, Yamagata A, Ito S, Imakiire T, et al. (April 2020). "PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Erythematosus". Journal of Immunology. 204 (8): 2043–2052. doi:10.4049/jimmunol.1900213. PMID 32169847.
  3. ^ Pezhman L, Hopkin SJ, Begum J, Heising S, Nasteska D, Wahid M, et al. (April 2023). "PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation". Clinical and Experimental Immunology. 212 (1): 1–10. doi:10.1093/cei/uxad022. PMC 10081110. PMID 36891817.
  4. ^ Alassiri M, Al Sufiani F, Aljohi M, Alanazi A, Alhazmi AS, Alrfaei BM, et al. (December 2023). "PEPITEM Treatment Ameliorates EAE in Mice by Reducing CNS Inflammation, Leukocyte Infiltration, Demyelination, and Proinflammatory Cytokine Production". International Journal of Molecular Sciences. 24 (24) 17243. doi:10.3390/ijms242417243. PMC 10743148. PMID 38139072.
  5. ^ Lewis JW, Frost K, Neag G, Wahid M, Finlay M, Northall EH, et al. (May 2024). "Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss". Cell Reports. Medicine. 5 (5) 101574. doi:10.1016/j.xcrm.2024.101574. PMC 11148860. PMID 38776873.
  6. ^ Hopkin SJ, Nathan P, Pezhman L, Begum J, Manning JE, Quinn LM, et al. (July 2024). "Rejuvenation of leukocyte trafficking in aged mice through PEPITEM intervention". npj Aging. 10 (1): 33. doi:10.1038/s41514-024-00160-6. PMC 11258258. PMID 39025913.
  7. ^ Alassiri M, Al Sufiani F, Aljohi M, Alanazi A, Alhazmi AS, Alrfaei BM, et al. (2024). "Prophylactic administration of PEPITEM in experimental autoimmune encephalomyelitis delays disease onset, inhibits leukocyte infiltration, and alleviates severity". International Journal of Clinical and Experimental Pathology. 17 (12): 492–505. doi:10.62347/LTAO2386. PMC 11711485. PMID 39802871.
  8. ^ Saviano A, et al. PEPITEM Tripeptides and Peptidomimetics: Next-Generation Modulators of Inflammation in Immune-Mediated Conditions. bioRxiv 2024.10.14.618151; doi:10.1101/2024.10.14.618151
  9. ^ Saviano A, Apta B, Tull S, Pezhman L, Fatima A, Sevim M, et al. (March 2025). "PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis". Pharmacological Research. 213 107624. doi:10.1016/j.phrs.2025.107624. PMID 39855372.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.